An FDA advisory committee is meeting Monday and Tuesday to discuss adverse neurologic effects following the use of epidural steroid injections for pain management.

Finding little relief for back and neck pain from analgesics or surgery, patients have turned to injectable steroids, but increasing reports of “catastrophic consequences,” including neurologic injuries, has put the treatment under scrutiny.

Regulators, stakeholders, and pain management experts will gather at the FDA’s White Oak conference center in Silver Spring, Md., to discuss the safety of injectable corticosteroids, among other topics.

READ FULL ARTICLE Curated publisher From Medical Page Today